Skip to main content
The PrismCDM Platform

From protocol to submission,
on one operating system.

PrismCDM produces a continuous thread of regulated output across the full clinical development lifecycle. Clinical Intelligence before the first patient is enrolled. Study Execution through every site and every visit. Inspection-ready Evidence continuously. End-to-end Provenance on every conclusion.

Every artifact produced by PrismCDM is generated by the same operating system, uses the same underlying evidence model, and shares the same provenance chain.

Free from a ClinicalTrials.gov NCT. Protocol synopsis and full-protocol analysis available through a 1-hour paid strategy session under NDA.

The Operating System in One Screen

One protocol. One operating system.
Six connected artifacts. One provenance chain.

One platform produces every artifact. Intelligence anchors on a public ClinicalTrials.gov protocol record; execution capabilities render representative structural views of what real customer studies look like in PrismCDM. Every artifact below is generated from the same underlying platform and shares the same provenance chain.

Study Story · Operating System Map
NCT02******

Demonstration. Intelligence stages (Protocol, Brief, Provenance) are anchored on a public ClinicalTrials.gov protocol record. Execution stages (Workspace, Evidence, Submission) show the platform's operator capabilities as representative structural views. They do not reflect any specific sponsor study managed by PrismCDM.

One platform. Six connected stages. One provenance chain.

This is the 15-second answer to “what is PrismCDM?” The same operating system carries a study through Protocol, Clinical Intelligence, Execution, Evidence, Submission, and Inspection, with each node grounded in a real artifact you can open.

Shared structural identifiers
Source record (Public)
ClinicalTrials.gov · NCT02******
Through-line finding pattern
FIND-*→REC-*(schema pattern)
  1. #1
    Public Protocol
    Protocol

    Source document

    Public protocol record ingested from ClinicalTrials.gov (NCT02******). The structured canonical fields anchor every downstream intelligence event.

  2. #2
    Public Protocol
    Clinical Intelligence

    Trial Intelligence Brief

    The engine analyzes the public protocol record. PTII™ composite + sub-indices, findings, and recommendations are issued. All sourced and reproducible.

    View artifact
  3. #3
    Execution

    Study Execution Workspace

    Operator-facing workspace that turns intelligence into operational decisions across site selection, screening reach, monitoring focus, and amendment workflow.

  4. #4
    Evidence

    Inspection Evidence Package

    Continuous evidence accumulation across operational events. Inspection-ready sections are composed as each capability progresses.

    View artifact
  5. #5
    Submission

    Submission Readiness Dashboard

    Composite readiness score + lifecycle progress + capability coverage. Updates as the engine + execution surfaces advance.

    View artifact
  6. #6
    Public Protocol
    Inspection

    Provenance Chain

    Every finding and recommendation traces from public source → engine extraction → assessment → recommendation. Verifiable. Reproducible. Inspection-ready.

    View artifact
The 15-second answer

PrismCDM is not a Trial Intelligence Brief tool. It is the operating system that produces a coherent thread of regulated output across the entire clinical development lifecycle. The same study you saw upstream is the same study you submit, the same study you defend at inspection, and the same study whose provenance verifies every conclusion.

The Brief is not a feature. It is proof of the platform.

Generated
Date
2026-07-15
Engine
Clinical Intelligence Engine v1.2
Assessment
PTII Assessment v1
Corpus Snapshot
Public Registry Snapshot 2026-07
Build
v1.6.3

Demonstration generated by PrismCDM using publicly available ClinicalTrials.gov protocol information (NCT02******). This analysis was independently produced by PrismCDM and has not been reviewed or endorsed by the study sponsor.

Platform Architecture

Two axes. One operating system.

Four capabilities operate at every stage of the clinical development lifecycle. The capabilities are horizontal; the lifecycle is vertical. The same Brief that emerges at Study Planning carries forward into Execution, Evidence, Submission, and Inspection through the same Provenance layer.

Axis 1 · Always-On CapabilitiesOperating at every stage below
Clinical Intelligence
Execution
Evidence
Provenance & Explainability
Axis 2 · The Clinical Development Path7 stages · Protocol to Inspection
  1. 1

    Protocol

    Source document ingested from ClinicalTrials.gov or uploaded by the sponsor team.

  2. 2

    Study Planning

    Trial Intelligence Brief generated. PTII™ composite + sub-indices. Findings and recommendations issued before the first patient is enrolled.

  3. 3

    Study Execution

    Operational workflow drives site activation, screening, monitoring, and data capture against the protocol intent.

  4. 4

    Clinical Data

    Captured, reconciled, and validated continuously against the locked protocol version and corpus snapshot.

  5. 5

    Evidence Generation

    Inspection Evidence Package grows continuously from operational events, not assembled at the end.

  6. 6

    Submission

    Submission Readiness Dashboard tracks the path to FDA filing. Package assembled from evidence already accumulated.

  7. 7

    Inspection

    Every conclusion verifiable through the Provenance Chain. Engine version, assessment version, corpus snapshot, build hash, evidence anchor. All present.

The same operating system. The same evidence model. The same provenance chain. End to end.

Early Access

See your protocol flow through the entire platform.

The clearest way to evaluate an operating system is to put one of your protocols through it. We'll generate the Trial Intelligence Brief, walk every finding and recommendation, and show how the same substrate carries through to execution, evidence, and submission.